Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
RNA
Stock Latest News
Company Announcements
Avidity Biosciences Reports Q1 2025 Earnings
4d ago
RNA
Premium
Ratings
Promising Outlook for Avidity Biosciences: Buy Rating Backed by Strategic Advancements and Product Launch Preparations
6d ago
RNA
Premium
The Fly
Avidity Biosciences price target lowered to $68 from $72 at H.C. Wainwright
6d ago
RNA
Premium
Pre-Earnings
Is RNA a Buy, Before Earnings?
7d ago
RNA
Premium
Ratings
Avidity Biosciences: Buy Rating Backed by Promising Pipeline Updates and Strong Financial Position
9d ago
RNA
Premium
Ratings
Avidity Biosciences: Promising Clinical Trials and Strong Financial Position Justify Buy Rating
10d ago
RNA
Premium
The Fly
Avidity Biosciences reports Q1 EPS (90c), consensus (88c)
10d ago
RNA
Premium
The Fly
Controversial doctor Vinay Prasad named CBER director, STAT reports
12d ago
DYN
RNA
Premium
The Fly
RBC sees Makary interview as potentially positive for biotech stocks
27d ago
DYN
RNA
Premium
Ratings
Avidity Biosciences: Strategic Advancements and Promising Pipeline Drive Buy Rating
30d ago
RNA
Premium
The Fly
Avidity Biosciences: Japan’s MHLW grants ODD to delpacibart etedesiran
1M ago
RNA
Premium
Ratings
Avidity Biosciences’ Promising Progress in FORTITUDE Study Boosts Buy Rating
2M ago
RNA
Premium
Ratings
Avidity Biosciences Positioned for Market Leadership with Strategic Advancements in Dystrophy Programs
2M ago
RNA
Premium
The Fly
Biotech stocks slide as Marks resignation seen being negative for sector
2M ago
DYN
MGX
Premium
The Fly
Marks resignation ‘not good’ for biotech sector, says RBC
2M ago
DYN
RNA
Premium
The Fly
Avidity Biosciences completes enrollment in Phase 1/2 Fortitude trial
2M ago
RNA
Premium
Ratings
Avidity Biosciences’ Promising Developments in DMD Treatment and Strategic Preparations for Future Success
2M ago
RNA
Premium
Ratings
Buy Rating for Avidity Biosciences Driven by Strategic Leadership and Patient-Centric Approach
2M ago
RNA
Premium
Ratings
Avidity Biosciences: Strategic Advancements in DMD Program and Promising Market Potential Justify Buy Rating
2M ago
RNA
Premium
Ratings
Optimistic Buy Rating for Avidity Biosciences Driven by Promising DMD Treatment and Strategic Expansion Plans
2M ago
RNA
Premium
Ratings
Promising Trial Results and Strong Growth Potential Lead to Buy Rating for Avidity Biosciences
2M ago
RNA
Premium
Ratings
Avidity Biosciences: Promising Trial Data and Future Prospects Justify Buy Rating
2M ago
RNA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
